Nanoemulsion: Concepts, development and applications in drug delivery

Journal of Controlled Release

Volumn 252, Issue , 2017, Pages 28-49

  Singh, Yuvraj ^a   Meher, Jaya Gopal ^a   Raval, Kavit ^a   Khan, Farooq Ali ^a   Chaurasia, Mohini ^b   Jain, Nitin K ^c   Chourasia, Manish K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b AMITY UNIVERSITY   (India)

^c Department of Biotechnology ^*  (India)

Author keywords

Clinical trials; Drug delivery; In vivo fate; Nanoemulsion; Oral; Ostwald ripening; Parenteral

Indexed keywords

DISPERSIONS; DRUG DELIVERY; EMULSIFICATION; MANUFACTURE; OSTWALD RIPENING; STRUCTURAL DYNAMICS; TARGETED DRUG DELIVERY;

CLINICAL TRIAL; IN-VIVO; NANOEMULSION; ORAL; PARENTERAL;

CONTROLLED DRUG DELIVERY;

ANTIOXIDANT; COSURFACTANT; EXCIPIENT; LIPID; OIL; PRESERVATIVE; DRUG; NANOPARTICLE; SURFACTANT;

CENTRIFUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; DYNAMICS; ENERGY; FLOW KINETICS; HUMAN; IN VITRO STUDY; KINETICS; NANOEMULSION; NANOFABRICATION; NONHUMAN; PH; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; SHEAR RATE; THERMODYNAMICS; VISCOSITY; CHEMISTRY; EMULSION; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PROCEDURES;

ADMINISTRATION, ORAL; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; DRUG STABILITY; EMULSIONS; EXCIPIENTS; HUMANS; NANOPARTICLES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; SURFACE-ACTIVE AGENTS;

EID: 85015027016     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2017.03.008     Document Type: Review

References (205)

1. [1] Mason, T.G., Wilking, J., Meleson, K., Chang, C., Graves, S., Nanoemulsions: formation, structure, and physical properties. J. Phys. Condens. Matter, 18, 2006, R635.
2. [2] Aboofazeli, R., Nanometric-Scaled Emulsions (Nanoemulsions). Iran. J. Pharm. Res.: IJPR 9 (2010), 325–326.
3. [3] Aulton, M.E., Taylor, K.M., Aulton's Pharmaceutics: The Design and Manufacture of Medicines. 2013, Elsevier Health Sciences.
4. [4] McClements, D.J., Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter 8 (2012), 1719–1729.
5. [5] Tan, S.L., Stanslas, J., Basri, M., Abedi Karjiban, R.A., Kirby, B.P., Sani, D., Basri, H.B., Nanoemulsion-based parenteral drug delivery system of carbamazepine: preparation, characterization, stability evaluation and blood-brain pharmacokinetics. Curr. Drug Deliv., 2015, 795–804.
6. [6] Sharma, N., Mishra, S., Sharma, S., Deshpande, R.D., Sharma, R.K., Preparation and optimization of nanoemulsions for targeting drug delivery. Int. J. Drug Dev. Res. 5:4 (2013), 37–48.
7. [7] Al-Edresi, S., Baie, S., Formulation and stability of whitening VCO-in-water nano-cream. Int. J. Pharm. 373 (2009), 174–178.
8. [8] Makidon, P.E., Nigavekar, S.S., Bielinska, A.U., Mank, N., Shetty, A.M., Suman, J., Knowlton, J., Myc, A., Rook, T., Baker, J.R. Jr., Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines. J. Aerosol. Med. Pulm. Drug. Deliv. 23 (2010), 77–89.
9. [9] Lala, R.R., Awari, N.G., Nanoemulsion-based gel formulations of COX-2 inhibitors for enhanced efficacy in inflammatory conditions. Appl. Nanosci. 4 (2014), 143–151.
10. [10] Hussain, A., Samad, A., Singh, S.K., Ahsan, M.N., Haque, M.W., Faruk, A., Ahmed, F.J., Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv. 23 (2016), 642–647.
11. [11] Nasr, M., Nawaz, S., Elhissi, A., Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. Int. J. Pharm. 436 (2012), 611–616.
12. [12] Amani, A., York, P., Chrystyn, H., Clark, B.J., Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. AAPS PharmSciTech 11 (2010), 1147–1151.
13. [13] D. Tamarkin, A. Besonov, M. Eini, J. Danziger, Foam prepared from nanoemulsions and uses, in, Google Patents, 2007.
14. [14] Mou, D., Chen, H., Du, D., Mao, C., Wan, J., Xu, H., Yang, X., Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Int. J. Pharm. 353 (2008), 270–276.
15. [15] Khani, S., Keyhanfar, F., Amani, A., Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Deliv. 23 (2016), 2035–2043.
16. [16] Pawar, V.K., Panchal, S.B., Singh, Y., Meher, J.G., Sharma, K., Singh, P., Bora, H.K., Singh, A., Datta, D., Chourasia, M.K., Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response. J. Control. Release 196 (2014), 295–306.
17. [17] Bhanushali, R.S., Gatne, M.M., Gaikwad, R.V., Bajaj, A.N., Morde, M.A., Nanoemulsion based intranasal delivery of antimigraine drugs for nose to brain targeting. Indian J. Pharm. Sci. 71 (2009), 707–709.
18. [18] Ammar, H.O., Salama, H.A., Ghorab, M., Mahmoud, A.A., Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech, 10, 2009, 808.
19. [19] Yukuyama, M.N., Ghisleni, D.D.M., Pinto, T.J.A., Bou-Chacra, N.A., Nanoemulsion: process selection and application in cosmetics – a review. Int. J. Cosmet. Sci. 38 (2016), 13–24.
20. [20] Wang, L., Li, X., Zhang, G., Dong, J., Eastoe, J., Oil-in-water nanoemulsions for pesticide formulations. J. Colloid Interface Sci. 314 (2007), 230–235.
21. [21] Zhang, Y., Shang, Z., Gao, C., Du, M., Xu, S., Song, H., Liu, T., Nanoemulsion for solubilization, stabilization, and in vitro Release of pterostilbene for oral delivery. AAPS PharmSciTech 15 (2014), 1000–1008.
22. [22] Jiang, S.-P., He, S.-N., Li, Y.-L., Feng, D.-L., Lu, X.-Y., Du, Y.-Z., Yu, H.-Y., Hu, F.-Q., Yuan, H., Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin. Int. J. Nanomedicine 8 (2013), 3141–3150.
23. [23] Devalapally, H., Zhou, F., McDade, J., Goloverda, G., Owen, A., Hidalgo, I.J., Silchenko, S., Optimization of PEGylated nanoemulsions for improved pharmacokinetics of BCS class II compounds. Drug Deliv. 22 (2015), 467–474.
24. [24] Yu, H., Huang, Q., Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J. Agric. Food Chem. 60 (2012), 5373–5379.
25. [25] Sun, W., Ma, X., Wei, X., Xu, Y., Nano composite emulsion for sustained drug release and improved bioavailability. Pharm. Res. 31 (2014), 2774–2783.
26. [26] Lu, R., Liu, S., Wang, Q., Li, X., Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement. Int. J. Nanomedicine 10 (2015), 4937–4946.
27. [27] Muheem, A., Shakeel, F., Jahangir, M.A., Anwar, M., Mallick, N., Jain, G.K., Warsi, M.H., Ahmad, F.J., A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi J. Pharm. 24 (2016), 413–428.
28. [28] Ensign, L.M., Cone, R., Hanes, J., Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliv. Rev. 64 (2012), 557–570.
29. [29] Khan, A.A., Mudassir, J., Mohtar, N., Darwis, Y., Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int. J. Nanomedicine 8 (2013), 2733–2744.
30. [30] Garti, N., Frenkel, M., Shwartz, R., Multiple emulsions. Part I: proposed technique to overcome unpleasant taste of drugs. J. Dispers. Sci. Technol. 4 (1983), 237–252.
31. [31] Sinko, P.J., Allen, L.V. Jr., Popovich, N.G., Ansel, H.C., Martin's Physical Pharmacy and Pharmaceutical Sciences. 2006.
32. [32] Anuchapreeda, S., Fukumori, Y., Okonogi, S., Ichikawa, H., Preparation of lipid nanoemulsions incorporating curcumin for cancer therapy. J. Nanotechnol., 2012, 2012, 11.
33. [33] Hwang, Y.Y., Ramalingam, K., Bienek, D.R., Lee, V., You, T., Alvarez, R., Antimicrobial activity of nanoemulsion in combination with cetylpyridinium chloride in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 57 (2013), 3568–3575.
34. [34] Ghosh, V., Mukherjee, A., Chandrasekaran, N., Eugenol-loaded antimicrobial nanoemulsion preserves fruit juice against, microbial spoilage. Colloids Surf. B Bio interfaces 114 (2014), 392–397.
35. [35] Abd-Elsalam, K.A., Khokhlov, A.R., Eugenol oil nanoemulsion: antifungal activity against Fusarium oxysporum f. sp. vasinfectum and phytotoxicity on cottonseeds. Appl. Nanosci. 5 (2015), 255–265.
36. [36] Vyas, T.K., Shahiwala, A., Amiji, M.M., Improved oral bioavailability and brain transport of saquinavir upon administration in novel nanoemulsion formulations. Int. J. Pharm. 347 (2008), 93–101.
37. [37] Bernardi, D.S., Pereira, T.A., Maciel, N.R., Bortoloto, J., Viera, G.S., Oliveira, G.C., Rocha-Filho, P.A., Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments. J. Nanobiotechnol., 9, 2011, 44.
38. [38] Ozturk, B., Argin, S., Ozilgen, M., McClements, D.J., Formation and stabilization of nanoemulsion-based vitamin E delivery systems using natural biopolymers: whey protein isolate and gum arabic. Food Chem. 188 (2015), 256–263.
39. [39] Morais Diane, J.M., Burgess, J., Vitamin E nanoemulsions characterization and analysis. Int. J. Pharm. 465 (2014), 455–463.
40. [40] Ali, M.S., Alam, M.S., Alam, N., Siddiqui, M.R., Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy. Iran. J. Pharm. Res. 13 (2014), 1125–1140.
41. [41] Sharif Makhmalzadeh, B., Torabi, S., Azarpanah, A., Optimization of ibuprofen delivery through rat skin from traditional and novel nanoemulsion formulations. Iran J. Pharm. Res. 11 (2012), 47–58.
42. [42] Belhaj, N., Arab-Tehrany, E., Linder, M., Oxidative kinetics of salmon oil in bulk and in nanoemulsion stabilized by marine lecithin. Process Biochem. 45 (2010), 187–195.
43. [43] McClements, D.J., Xiao, H., Potential biological fate of ingested nanoemulsions: influence of particle characteristics. Food Funct. 3 (2012), 202–220.
44. [44] Klang, V., Valenta, C., Lecithin-based nanoemulsions. J. Drug Deliv. Sci. Technol. 21 (2011), 55–76.
45. [45] Zhang, T., Dong, D., Lu, D., Wang, S., Wu, B., Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells. Int. J. Pharm. 501 (2016), 190–198.
46. [46] Wang, X., Jiang, Y., Wang, Y.-W., Huang, M.-T., Ho, C.-T., Huang, Q., Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem. 108 (2008), 419–424.
47. [47] Azeem, A., Rizwan, M., Ahmad, F.J., Iqbal, Z., Khar, R.K., Aqil, M., Talegaonkar, S., Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10 (2009), 69–76.
48. [48] Jo, Y.-J., Kwon, Y.-J., Characterization of β-carotene nanoemulsions prepared by microfluidization technique. Food Sci. Biotechnol. 23 (2014), 107–113.
49. [49] Polychniatou, V., Tzia, C., Study of formulation and stability of co-surfactant free water-in-olive oil nano- and submicron emulsions with food grade non-ionic surfactants. J. Am. Oil Chem. Soc. 91 (2014), 79–88.
50. [50] Jadhav, C., Kate, V., Payghan, S.A., Investigation of effect of non-ionic surfactant on preparation of griseofulvin non-aqueous nanoemulsion. J. Nanostruct. Chem. 5 (2015), 107–113.
51. [51] Scheller, K.J., Williams, S.J., Lawrence, A.J., Jarrott, B., Djouma, E., An improved method to prepare an injectable microemulsion of the galanin-receptor 3 selective antagonist, SNAP 37889, using Kolliphor® HS 15. MethodsX 1 (2014), 212–216.
52. [52] Brüsewitz, C., Schendler, A., Funke, A., Wagner, T., Lipp, R., Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. Int. J. Pharm. 329 (2007), 173–181.
53. [53] Erramreddy, V.V., Ghosh, S., Influence of emulsifier concentration on nanoemulsion gelation. Langmuir 30 (2014), 11062–11074.
54. [54] Uluata, S., Decker, E.A., McClements, D.J., Optimization of nanoemulsion fabrication using microfluidization: role of surfactant concentration on formation and stability. Food Biophysics 11 (2016), 52–59.
55. [55] He, W., Tan, Y., Tian, Z., Chen, L., Hu, F., Wu, W., Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in vitro characterization, and pharmacokinetics in rats. Int. J. Nanomedicine 6 (2011), 521–533.
56. [56] Maher, P.G., Fenelon, M.A., Zhou, Y., Kamrul Haque, M., Roos, Y.H., Optimization of beta-casein stabilized nanoemulsions using experimental mixture design. J. Food Sci. 76 (2011), C1108–C1117.
57. [57] Ali, A., Mekhloufi, G., Huang, N., Agnely, F., Beta-lactoglobulin stabilized nanemulsions—formulation and process factors affecting droplet size and nanoemulsion stability. Int. J. Pharm. 500 (2016), 291–304.
58. [58] Combrinck, J., Otto, A., du Plessis, J., Whey protein/polysaccharide-stabilized emulsions: effect of polymer type and pH on release and topical delivery of salicylic acid. AAPS PharmSciTech 15 (2014), 588–600.
59. [59] Rapoport, N., Christensen, D.A., Kennedy, A.M., Nam, K., Cavitation properties of block copolymer stabilized phase-shift nanoemulsions used as drug carriers. Ultrasound Med. Biol. 36 (2010), 419–429.
60. [60] Li, W., Chen, H., He, Z., Han, C., Liu, S., Li, Y., Influence of surfactant and oil composition on the stability and antibacterial activity of eugenol nanoemulsions. LWT Food Sci. Technol. 62 (2015), 39–47.
61. [61] Buranasuksombat, U., Kwon, Y.J., Turner, M., Bhandari, B., Influence of emulsion droplet size on antimicrobial properties. Food Sci. Biotechnol. 20 (2011), 793–800.
62. [62] Hak, S., Garaiova, Z., Olsen, L.T., Nilsen, A.M., de Lange Davies, C., The effects of oil-in-water nanoemulsion polyethylene glycol surface density on intracellular stability, pharmacokinetics, and biodistribution in tumor bearing mice. Pharm. Res. 32 (2015), 1475–1485.
63. [63] Emanuele, M., Balasubramaniam, B., Differential effects of commercial-grade and purified poloxamer 188 on renal function. Drugs R D 14 (2014), 73–83.
64. [64] Loureiro, A., Abreu, A.S., Sárria, M.P., Figueiredo, M.C., Saraiva, L.M., Bernardes, G.J., Gomes, A.C., Cavaco-Paulo, A., Functionalized protein nanoemulsions by incorporation of chemically modified BSA. RSC Adv. 5 (2015), 4976–4983.
65. [65] Lante, A., Friso, D., Oxidative stability and rheological properties of nanoemulsions with ultrasonic extracted green tea infusion. Food Res. Int. 54 (2013), 269–276.
66. [66] Forgiarini, A., Esquena, J., González, C., Solans, C., Formation of nano-emulsions by low-energy emulsification methods at constant temperature. Langmuir 17 (2001), 2076–2083.
67. [67] Wooster, T.J., Golding, M., Sanguansri, P., Impact of oil type on nanoemulsion formation and Ostwald ripening stability. Langmuir 24 (2008), 12758–12765.
68. [68] Tadros, T., Izquierdo, P., Esquena, J., Solans, C., Formation and stability of nano-emulsions. Adv. Colloid Interf. Sci. 108–109 (2004), 303–318.
69. [69] McClements, D.J., Food Emulsions: Principles, Practices, and Techniques. 2015, CRC press.
70. [70] Aguilera, J.M., Stanley, D.W., Microstructural Principles of Food Processing and Engineering. Springer Science & Business Media, 1999.
71. [71] Junghanns, J.-U.A., Müller, R.H., Nanocrystal technology, drug delivery and clinical applications. Int. J. Nanomedicine, 3, 2008, 295.
72. [72] Mahdi Jafari, S., He, Y., Bhandari, B., Nano-emulsion production by sonication and microfluidization—a comparison. Int. J. Food Prop. 9 (2006), 475–485.
73. [73] Gogate, P.R., Kabadi, A.M., A review of applications of cavitation in biochemical engineering/biotechnology. Biochem. Eng. J. 44 (2009), 60–72.
74. [74] Leong, T.S., Wooster, T.J., Kentish, S.E., Ashokkumar, M., Minimising oil droplet size using ultrasonic emulsification. Ultrason. Sonochem. 16 (2009), 721–727.
75. [75] Neslihan Gursoy, R., Benita, S., Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004), 173–182.
76. [76] Bouchemal, K., Briançon, S., Perrier, E., Fessi, H., Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int. J. Pharm. 280 (2004), 241–251.
77. [77] Fernandez, P., André, V., Rieger, J., Kühnle, A., Nano-emulsion formation by emulsion phase inversion. Colloids Surf. A Physicochem. Eng. Asp. 251 (2004), 53–58.
78. [78] Ostertag, F., Weiss, J., McClements, D.J., Low-energy formation of edible nanoemulsions: factors influencing droplet size produced by emulsion phase inversion. J. Colloid Interface Sci. 388 (2012), 95–102.
79. [79] Capek, I., Degradation of kinetically-stable o/w emulsions. Adv. Colloid Interf. Sci. 107 (2004), 125–155.
80. [80] Asthana, S., Jaiswal, A.K., Gupta, P.K., Pawar, V.K., Dube, A., Chourasia, M.K., Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules. Antimicrob. Agents Chemother. 57 (2013), 1714–1722.
81. [81] Bachmann, L., Freeze-etching of dispersions, emulsions and macromolecular solutions of biological interest. Steinbrecht, R., Zierold, K., (eds.) Cryotechniques in Biological Electron Microscopy, 1987, Springer, Berlin Heidelberg, 192–204.
82. [82] Grapentin, C., Barnert, S., Schubert, R., Monitoring the stability of perfluorocarbon nanoemulsions by cryo-TEM image analysis and dynamic light scattering. PLoS One, 10, 2015, e0130674.
83. [83] Kislukhin, A.A., Xu, H., Adams, S.R., Narsinh, K.H., Tsien, R.Y., Ahrens, E.T., Paramagnetic fluorinated nanoemulsions for sensitive cellular fluorine-19 magnetic resonance imaging. Nat. Mater. 15 (2016), 662–668.
84. [84] Piorkowski, D.T., McClements, D.J., Beverage emulsions: recent developments in formulation, production, and applications. Food Hydrocoll. 42:Pt 1 (2014), 5–41.
85. [85] Lifshitz, I.M., Slyozov, V.V., The kinetics of precipitation from supersaturated solid solutions. J. Phys. Chem. Solids 19 (1961), 35–50.
86. [86] Kabalnov, A.S., Shchukin, E.D., Ostwald ripening theory: applications to fluorocarbon emulsion stability. Adv. Colloid Interf. Sci. 38 (1992), 69–97.
87. [87] Fryd, M.M., Mason, T.G., Advanced nanoemulsions. Annu. Rev. Phys. Chem. 63 (2012), 493–518.
88. [88] Delmas, T., Piraux, H.L.N., Couffin, A.C., Texier, I., Vinet, F.O., Poulin, P., Cates, M.E., Bibette, J.R.M., How to prepare and stabilize very small nanoemulsions. Langmuir 27 (2011), 1683–1692.
89. [89] Fryd, M.M., Mason, T.G., Time-dependent nanoemulsion droplet size reduction by evaporative ripening. J. Phys. Chem. Lett. 1 (2010), 3349–3353.
90. [90] Nam, Y.S., Kim, J.W., Shim, J., Han, S.H., Kim, H.K., Nanosized emulsions stabilized by semisolid polymer interphase. Langmuir 26 (2010), 13038–13043.
91. [91] Persson, E.M., Nilsson, R.G., Hansson, G.I., Löfgren, L.J., Libäck, F., Knutson, L., Abrahamsson, B., Lennernäs, H., A clinical single-pass perfusion investigation of the dynamic in vivo secretory response to a dietary meal in human proximal small intestine. Pharm. Res. 23 (2006), 742–751.
92. [92] Porter, C.J., Trevaskis, N.L., Charman, W.N., Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6 (2007), 231–248.
93. [93] Collnot, E.M., Baldes, C., Schaefer, U.F., Edgar, K.J., Wempe, M.F., Lehr, C.M., Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol. Pharm. 7 (2010), 642–651.
94. [94] Lin, Y., Shen, Q., Katsumi, H., Okada, N., Fujita, T., Jiang, X., Yamamoto, A., Effects of labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats. Biol. Pharm. Bull. 30 (2007), 1301–1307.
95. [95] Khandavilli, S., Panchagnula, R., Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. J. Investig. Dermatol. 127 (2007), 154–162.
96. [96] Aggarwal, P., Hall, J.B., McLeland, C.B., Dobrovolskaia, M.A., McNeil, S.E., Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61 (2009), 428–437.
97. [97] Szebeni, J., Alving, C.R., Rosivall, L., Bunger, R., Baranyi, L., Bedocs, P., Toth, M., Barenholz, Y., Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J. Liposome Res. 17 (2007), 107–117.
98. [98] Baccarin, T., Mitjans, M., Lemos-Senna, E., Vinardell, M.P., Protection against oxidative damage in human erythrocytes and preliminary photosafety assessment of Punica granatum seed oil nanoemulsions entrapping polyphenol-rich ethyl acetate fraction. Toxicol. in Vitro 30 (2015), 421–428.
99. [99] Li, X., Du, L., Wang, C., Liu, Y., Mei, X., Jin, Y., Highly efficient and lowly toxic docetaxel nanoemulsions for intravenous injection to animals. Pharmazie 66 (2011), 479–483.
100. [100] Desai, N., Challenges in development of nanoparticle-based therapeutics. AAPS J. 14 (2012), 282–295.
101. [101] Singh, K.K., Vingkar, S.K., Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. Int. J. Pharm. 347 (2008), 136–143.
102. [102] Levison, M.E., Levison, J.H., Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect. Dis. Clin. N. Am. 23 (2009), 791–vii.
103. [103] Ganta, S., Talekar, M., Singh, A., Coleman, T.P., Amiji, M.M., Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy. AAPS PharmSciTech 15 (2014), 694–708.
104. [104] Kuhn, D.A., Vanhecke, D., Michen, B., Blank, F., Gehr, P., Petri-Fink, A., Rothen-Rutishauser, B., Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J. Nanotechnol. 5 (2014), 1625–1636.
105. [105] Kou, L., Sun, J., Zhai, Y., He, Z., The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J. Pharm. Sci. 8 (2013), 1–10.
106. [106] Maranhao, R.C., Roland, I.A., Toffoletto, O., Ramires, J.A., Goncalves, R.P., Mesquita, C.H., Pileggi, F., Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to low density lipoprotein receptors. Lipids 32 (1997), 627–633.
107. [107] Rodrigues, D.G., Maria, D.A., Fernandes, D.C., Valduga, C.J., Couto, R.D., Ibanez, O.C., Maranhao, R.C., Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies. Cancer Chemother. Pharmacol. 55 (2005), 565–576.
108. [108] Valduga, C.J., Fernandes, D.C., Lo Prete, A.C., Azevedo, C.H., Rodrigues, D.G., Maranhao, R.C., Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide. J. Pharm. Pharmacol. 55 (2003), 1615–1622.
109. [109] Maranhao, R.C., Graziani, S.R., Yamaguchi, N., Melo, R.F., Latrilha, M.C., Rodrigues, D.G., Couto, R.D., Schreier, S., Buzaid, A.C., Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Cancer Chemother. Pharmacol. 49 (2002), 487–498.
110. [110] Ye, J., Liu, Y., Xia, X., Meng, L., Dong, W., Wang, R., Fu, Z., Liu, H., Han, R., Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors. Oncol. Rep. 36 (2016), 399–409.
111. [111] Ye, J., Xia, X., Dong, W., Hao, H., Meng, L., Yang, Y., Wang, R., Lyu, Y., Liu, Y., Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines. Int. J. Nanomedicine 11 (2016), 4125–4140.
112. [112] Singh, Y., Tomar, S., Khan, S., Meher, J.G., Pawar, V.K., Raval, K., Sharma, K., Singh, P.K., Chaurasia, M., Surendar Reddy, B., Chourasia, M.K., Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes. J. Control. Release 220 (2015), 368–387.
113. [113] Singh, Y., Tomar, S., Khan, S., Meher, J.G., Pawar, V.K., Raval, K., Sharma, K., Singh, P.K., Chaurasia, M., Surendar Reddy, B., Chourasia, M.K., Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes. J. Control. Release 220:Pt A (2015), 368–387.
114. [114] Ganta, S., Sharma, P., Paxton, J.W., Baguley, B.C., Garg, S., Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion. J. Drug Target. 18 (2010), 125–133.
115. [115] Monteagudo, E., Gándola, Y., González, L., Bregni, C., Carlucci, A.M., Development, characterization, and in vitro evaluation of tamoxifen microemulsions. J. Drug Deliv., 2012, 2012, 236713.
116. [116] Tagne, J.-B., Kakumanu, S., Ortiz, D., Shea, T., Nicolosi, R.J., A nanoemulsion formulation of tamoxifen increases its efficacy in a breast cancer cell line. Mol. Pharm. 5 (2008), 280–286.
117. [117] Bawa, R., Audette, G.F., Reese, B., Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. 2016, CRC Press.
118. [118] Ramreddy, S., Kandadi, P., Veerabrahma, K., Formulation and pharmacokinetics of diclofenac lipid nanoemulsions for parenteral application. PDA J. Pharm. Sci. Technol. 66 (2012), 28–37.
119. [119] Hak, S., Helgesen, E., Hektoen, H.H., Huuse, E.M., Jarzyna, P.A., Mulder, W.J., Haraldseth, O., Davies Cde, L., The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging. ACS Nano 6 (2012), 5648–5658.
120. [120] Kansal, S., Tandon, R., Dwivedi, P., Misra, P., Verma, P.R., Dube, A., Mishra, P.R., Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. J. Antimicrob. Chemother. 67 (2012), 2650–2660.
121. [121] Ganta, S., Amiji, M., Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol. Pharm. 6 (2009), 928–939.
122. [122] Ma, Y., Liu, D., Wang, D., Wang, Y., Fu, Q., Fallon, J.K., Yang, X., He, Z., Liu, F., Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer. Mol. Pharm. 11 (2014), 2623–2630.
123. [123] Meng, L., Xia, X., Yang, Y., Ye, J., Dong, W., Ma, P., Jin, Y., Liu, Y., Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition. Int. J. Pharm. 513 (2016), 8–16.
124. [124] Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12 (2013), 991–1003.
125. [125] Zhou, Q.L., Chen, Z.Y., Wang, Y.X., Yang, F., Lin, Y., Liao, Y.Y., Ultrasound-mediated local drug and gene delivery using nanocarriers. Biomed. Res. Int., 2014, 2014, 963891.
126. [126] Baghbani, F., Moztarzadeh, F., Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets. Colloids Surf. B Biointerfaces 153 (2017), 132–140.
127. [127] Rapoport, N.Y., Kennedy, A.M., Shea, J.E., Scaife, C.L., Nam, K.H., Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J. Control. Release 138 (2009), 268–276.
128. [128] Kelmann, R.G., Kuminek, G., Teixeira, H.F., Koester, L.S., Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. Int. J. Pharm. 342 (2007), 231–239.
129. [129] Araújo, F.A., Kelmann, R.G., Araújo, B.V., Finatto, R.B., Teixeira, H.F., Koester, L.S., Development and characterization of parenteral nanoemulsions containing thalidomide. Eur. J. Pharm. Sci. 42 (2011), 238–245.
130. [130] Venkateshwarlu, I., Prabhakar, K., Ali, M., Kishan, V., Development and in vitro cytotoxic evaluation of parenteral docetaxel lipid nanoemulsions for application in cancer treatment. PDA J. Pharm. Sci. Technol. 64 (2010), 233–241.
131. [131] Ragelle, H., Crauste-Manciet, S., Seguin, J., Brossard, D., Scherman, D., Arnaud, P., Chabot, G.G., Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice. Int. J. Pharm. 427 (2012), 452–459.
132. [132] Simon, M., Wittmar, M., Bakowsky, U., Kissel, T., Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol))]-graft-poly(L-lactic acid): a novel carrier for transmucosal delivery of peptides. Bioconjug. Chem. 15 (2004), 841–849.
133. [133] Borhade, V., Pathak, S., Sharma, S., Patravale, V., Clotrimazole nanoemulsion for malaria chemotherapy. Part I: preformulation studies, formulation design and physicochemical evaluation. Int. J. Pharm. 431 (2012), 138–148.
134. [134] Desai, A., Vyas, T., Amiji, M., Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations. J. Pharm. Sci. 97 (2008), 2745–2756.
135. [135] Yang, X., Wang, D., Ma, Y., Zhao, Q., Fallon, J.K., Liu, D., Xu, X.E., Wang, Y., He, Z., Liu, F., Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging. Nanomedicine 9 (2014), 2773–2785.
136. [136] Gao, F., Zhang, Z., Bu, H., Huang, Y., Gao, Z., Shen, J., Zhao, C., Li, Y., Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism. J. Control. Release 149 (2011), 168–174.
137. [137] Sun, H., Liu, K., Liu, W., Wang, W., Guo, C., Tang, B., Gu, J., Zhang, J., Li, H., Mao, X., Zou, Q., Zeng, H., Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs. Int. J. Nanomedicine 7 (2012), 5529–5543.
138. [138] Li, X., Qi, J., Xie, Y., Zhang, X., Hu, S., Xu, Y., Lu, Y., Wu, W., Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats. Int. J. Nanomedicine 8 (2013), 23–32.
139. [139] Prego, C., Torres, D., Fernandez-Megia, E., Novoa-Carballal, R., Quiñoá, E., Alonso, M.J., Chitosan–PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree. J. Control. Release 111 (2006), 299–308.
140. [140] Tiwari, S.B., Amiji, M.M., Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J. Nanosci. Nanotechnol. 6 (2006), 3215–3221.
141. [141] Monteiro, L.M., Lione, V.F., Do Carmo, F.A., Do Amaral, L.H., Da Silva, J.H., Nasciutti, L.E., Rodrigues, C.R., Castro, H.C., De Sousa, V.P., Cabral, L.M., Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies. Int. J. Nanomedicine 7 (2012), 5175–5182.
142. [142] Tang, S.Y., Sivakumar, M., Ng, A.M.-H., Shridharan, P., Anti-inflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. Int. J. Pharm. 430 (2012), 299–306.
143. [143] Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F.J., Khar, R.K., Ali, M., Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 66 (2007), 227–243.
144. [144] Parveen, R., Baboota, S., Ali, J., Ahuja, A., Vasudev, S.S., Ahmad, S., Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies. Int. J. Pharm. 413 (2011), 245–253.
145. [145] Shen, Q., Wang, Y., Zhang, Y., Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer. Int. J. Nanomedicine 6 (2011), 1237–1243.
146. [146] Soliman, K.A., Ibrahim, H.K., Ghorab, M.M., Formulation of avanafil in a solid self-nanoemulsifying drug delivery system for enhanced oral delivery. Eur. J. Pharm. Sci. 93 (2016), 447–455.
147. [147] Shukla, M., Jaiswal, S., Sharma, A., Srivastava, P.K., Arya, A., Dwivedi, A.K., Lal, J., A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Dev. Ind. Pharm., 2016, 1–15.
148. [148] Ke, Z., Hou, X., Jia, X.-b., Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Des. Dev. Ther., 10, 2016, 2049.
149. [149] Motawea, A., Borg, T., Tarshoby, M., Abd El-Gawad, A.E.-G.H., Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam. Pharm. Dev. Technol., 2016, 1–12.
150. [150] Mahmood, A., Prüfert, F., Efiana, N.A., Ashraf, M.I., Hermann, M., Hussain, S., Bernkop-Schnürch, A., Cell-penetrating self-nanoemulsifying drug delivery systems (SNEDDS) for oral gene delivery. Expert Opin. Drug Deliv. 13 (2016), 1503–1512.
151. [151] Chai, F., Sun, L., Ding, Y., Liu, X., Zhang, Y., Webster, T.J., Zheng, C., A solid self-nanoemulsifying system of the BCS class IIb drug dabigatran etexilate to improve oral bioavailability. Nanomedicine 11 (2016), 1801–1816.
152. [152] Akhtar, J., Siddiqui, H.H., Fareed, S., Badruddeen, Khalid, M., Aqil, M., Nanoemulsion: for improved oral delivery of repaglinide. Drug Deliv. 23 (2016), 2026–2034.
153. [153] Choudhury, H., Gorain, B., Karmakar, S., Biswas, E., Dey, G., Barik, R., Mandal, M., Pal, T.K., Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. Int. J. Pharm. 460 (2014), 131–143.
154. [154] Hu, J., Chen, D., Jiang, R., Tan, Q., Zhu, B., Zhang, J., Improved absorption and in vivo kinetic characteristics of nanoemulsions containing evodiamine–phospholipid nanocomplex. Int. J. Nanomedicine, 9, 2014, 4411.
155. [155] Laxmi, M., Bhardwaj, A., Mehta, S., Mehta, A., Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether. Artif. Cells Nanomed. Biotechnol. 43 (2015), 334–344.
156. [156] Li, P., Tan, A., Prestidge, C.A., Nielsen, H.M., Müllertz, A., Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading. Int. J. Pharm. 477 (2014), 390–398.
157. [157] Ma, Y., Li, H., Guan, S., Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system. Drug Dev. Ind. Pharm. 41 (2015), 177–182.
158. [158] Verma, P., Meher, J.G., Asthana, S., Pawar, V.K., Chaurasia, M., Chourasia, M.K., Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer. Drug deliv. 23 (2016), 479–488.
159. [159] Shakeel, F., Ramadan, W., Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids Surf. B: Biointerfaces 75 (2010), 356–362.
160. [160] Kuo, F., Subramanian, B., Kotyla, T., Wilson, T.A., Yoganathan, S., Nicolosi, R.J., Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties. Int. J. Pharm. 363 (2008), 206–213.
161. [161] Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Shafiq, S., Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment. J. Drug Target. 16 (2008), 733–740.
162. [162] Wu, H., Ramachandran, C., Bielinska, A.U., Kingzett, K., Sun, R., Weiner, N.D., Roessler, B.J., Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int. J. Pharm. 221 (2001), 23–34.
163. [163] Wu, H., Ramachandran, C., Weiner, N.D., Roessler, B.J., Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int. J. Pharm. 220 (2001), 63–75.
164. [164] Tagne, J.-B., Kakumanu, S., Nicolosi, R.J., Nanoemulsion preparations of the anticancer drug dacarbazine significantly increase its efficacy in a xenograft mouse melanoma model. Mol. Pharm. 5 (2008), 1055–1063.
165. [165] Kakumanu, S., Tagne, J.B., Wilson, T.A., Nicolosi, R.J., A nanoemulsion formulation of dacarbazine reduces tumor size in a xenograft mouse epidermoid carcinoma model compared to dacarbazine suspension. Nanomedicine 7 (2011), 277–283.
166. [166] Hamouda, T., Hayes, M.M., Cao, Z., Tonda, R., Johnson, K., Wright, D.C., Brisker, J., Baker, J.R. Jr., A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J. Infect. Dis. 180 (1999), 1939–1949.
167. [167] Myc, A., Vanhecke, T., Landers, J.J., Hamouda, T., Baker, J.R. Jr., The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi. Mycopathologia 155 (2002), 195–201.
168. [168] Hussain, A., Singh, S., Webster, T.J., Ahmad, F.J., New perspectives in the topical delivery of optimized amphotericin B loaded nanoemulsions using excipients with innate anti-fungal activities: a mechanistic and histopathological investigation. Nanomedicine 13 (2017), 1117–1126.
169. [169] I. Tamayo, C. Gamazo, J. de Souza Rebouças, J.M. Irache, Topical immunization using a nanoemulsion containing bacterial membrane antigens, J. Drug Deliv. Sci. Technol. Doi: 10.1016/j.jddst.2017.02.009.
170. [170] Zhou, H., Yue, Y., Liu, G., Li, Y., Zhang, J., Gong, Q., Yan, Z., Duan, M., Preparation and characterization of a lecithin nanoemulsion as a topical delivery system. Nanoscale Res. Lett. 5 (2009), 224–230.
171. [171] Ali, M.S., Alam, M.S., Imam, F.I., Topical nanoemulsion of turmeric oil for psoriasis: characterization, ex vivo and in vivo assessment. Int. J. Drug Deliv. 4 (2012), 184–197.
172. [172] Hamouda, T., Myc, A., Donovan, B., Shih, A.Y., Reuter, J.D., Baker, J.R., A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol. Res. 156 (2001), 1–7.
173. [173] Yilmaz, E., Borchert, H.-H., Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. Eur. J. Pharm. Biopharm. 60 (2005), 91–98.
174. [174] Hagigit, T., Abdulrazik, M., Orucov, F., Valamanesh, F., Lambert, M., Lambert, G., Behar-Cohen, F., Benita, S., Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye. J. Control. Release 145 (2010), 297–305.
175. [175] Alves, M.P., Scarrone, A.L., Santos, M., Pohlmann, A.R., Guterres, S.S., Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int. J. Pharm. 341 (2007), 215–220.
176. [176] Hagigit, T., Abdulrazik, M., Valamanesh, F., Behar-Cohen, F., Benita, S., Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice. J. Control. Release 160 (2012), 225–231.
177. [177] Patel, N., Nakrani, H., Raval, M., Sheth, N., Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability. Drug Deliv., 2016, 1–12.
178. [178] Lim, C., Kim, D.-w., Sim, T., Hoang, N.H., Lee, J.W., Lee, E.S., Youn, Y.S., Oh, K.T., Preparation and characterization of a lutein loading nanoemulsion system for ophthalmic eye drops. J. Drug Deliv. Sci. Technol. 36 (2016), 168–174.
179. [179] Kumar, M., Misra, A., Babbar, A.K., Mishra, A.K., Mishra, P., Pathak, K., Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int. J. Pharm. 358 (2008), 285–291.
180. [180] Das, S.C., Hatta, M., Wilker, P.R., Myc, A., Hamouda, T., Neumann, G., Baker, J.R. Jr., Kawaoka, Y., Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. Vaccine 30 (2012), 6871–6877.
181. [181] Orzechowska, B.U., Kukowska-Latallo, J.F., Coulter, A.D., Szabo, Z., Gamian, A., Myc, A., Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells. Vaccine 33 (2015), 2289–2296.
182. [182] Yadav, S., Gandham, S.K., Panicucci, R., Amiji, M.M., Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation. Nanomedicine 12 (2016), 987–1002.
183. [183] Pidaparthi, K., Suares, D., Comparison of nanoemulsion and aqueous micelle systems of Paliperidone for intranasal delivery. AAPS PharmSciTech, 2016, 1–10.
184. [184] Shobhit, K., Javed, A., Sanjula, B., Design Expert ® supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson's disease. Nanotechnology, 27, 2016, 435101.
185. [185] Kumar, A., Jain, S.K., Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method. Artifi. Cells Nanomed. Biotechnol., 1–7, 2016.
186. [186] Boche, M., Pokharkar, V., Quetiapine nanoemulsion for intranasal drug delivery: evaluation of brain-targeting efficiency. AAPS PharmSciTech, 2016, 1–11.
187. [187] Yogendra Raj, P., Shobhit, K., Bijay Kumar, G., Javed, A., Sanjula, B., Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Nanotechnology, 27, 2016, 025102.
188. [188] Mahajan, H.S., Mahajan, M.S., Nerkar, P.P., Agrawal, A., Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting. Drug Deliv. 21 (2014), 148–154.
189. [189] Kumar, M., Misra, A., Pathak, K., Formulation and characterization of nanoemulsion of olanzapine for intranasal delivery. PDA J. Pharm. Sci. Technol. 63 (2009), 501–511.
190. [190] Botelho, M., Queiroz, D., Freitas, A., Guerreiro, S., Umbelino, S., Barros, G., Effects of a new testosterone transdermal delivery system, Biolipid B2-testosterone in healthy middle aged men: a Confocal Raman Spectroscopy Study. J. Pharm. Sci. Innov. 2 (2013), 1–7.
191. [191] Maisch, T., Santarelli, F., Schreml, S., Babilas, P., Szeimies, R.M., Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model. Exp. Dermatol. 19 (2010), e302–e305.
192. [192] de Bruijn, H.S., Brooks, S., van der Ploeg-van den Heuvel, A., ten Hagen, T.L.M., de Haas, E.R.M., Robinson, D.J., Light fractionation significantly increases the efficacy of photodynamic therapy using BF-200 ALA in normal mouse skin. PLoS One, 11, 2016, e0148850.
193. [193] Lourenço-Filho, D.D., Maranhao, R.C., Méndez-Contreras, C.A., Tavares, E.R., Freitas, F.R., Stolf, N.A., An artificial nanoemulsion carrying paclitaxel decreases the transplant heart vascular disease: a study in a rabbit graft model. J. Thorac. Cardiovasc. Surg. 141 (2011), 1522–1528.
194. [194] Dantas, S.A., Ficker, E.S., Vinagre, C.G., Ianni, B.M., Maranhão, R.C., Mady, C., Metabolism of a lipid nanoemulsion resembling low-density lipoprotein in patients with grade III obesity. Clinics 65 (2010), 23–27.
195. [195] Favero, G.M., Maranhão, R.C., Maria, D.A., Levy, D., Bydlowski, S.P., Synthetic nanoemulsion resembling a protein-free model of 7-ketocholesterol containing low density lipoprotein: in vitro and in vivo studies. Biol. Res. 43 (2010), 439–444.
196. [196] Jafari, S.M., He, Y., Bhandari, B., Production of sub-micron emulsions by ultrasound and microfluidization techniques. J. Food Eng. 82 (2007), 478–488.
197. [197] Kentish, S., Wooster, T.J., Ashokkumar, M., Balachandran, S., Mawson, R., Simons, L., The use of ultrasonics for nanoemulsion preparation. Innovative Food Sci. Emerg. Technol. 9 (2008), 170–175.
198. [198] Fang, J.-H., Hora, M., The adjuvant MF59: a 10-year perspective Gary Ott, Ramachandran Radhakrishnan. O'Hagan, D.T., (eds.) Vaccine Adjuvants: Preparation Methods and Research Protocols, 2000, Springer New York, Totowa, NJ, 211–228.
199. [199] Schultze, V., D'Agosto, V., Wack, A., Novicki, D., Zorn, J., Hennig, R., Safety of MF59™ adjuvant. Vaccine 26 (2008), 3209–3222.
200. [200] Liu, L., Bagia, C., Janjic, J.M., The first scale-up production of theranostic nanoemulsions. BioRes. Open Access 4 (2015), 218–228.
201. [201] Betts, J.N., Johnson, M.G., Rygiewicz, P.T., King, G.A., Andersen, C.P., Potential for metal contamination by direct sonication of nanoparticle suspensions. Environ. Toxicol. Chem. 32 (2013), 889–893.
202. [202] Peshkovsky, A.S., Peshkovsky, S.L., Bystryak, S., Scalable high-power ultrasonic technology for the production of translucent nanoemulsions. Chem. Eng. Process. Process Intensif. 69 (2013), 77–82.
203. [203] Mason, T.J., Joyce, E., Phull, S.S., Lorimer, J.P., Potential uses of ultrasound in the biological decontamination of water. Ultrason. Sonochem. 10 (2003), 319–323.
204. [204] Muqbil, I., Burke, F.J.T., Miller, C.H., Palenik, C.J., Antimicrobial activity of ultrasonic cleaners. J. Hosp. Infect. 60 (2005), 249–255.
205. [205] Maa, Y.F., Hsu, C.C., Performance of sonication and microfluidization for liquid-liquid emulsification. Pharm. Dev. Technol. 4 (1999), 233–240.